Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Influenza and Acute Respiratory Viral Infections”

103 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 103 results

Testing effectiveness (Phase 2)UnknownNCT04298060
What this trial is testing

DAS181 for Patients With Severe Hospitalized Flu and SAD-RVs (COVID-19)

Who this might be right for
Influenza InfectionSAD-RV Infection and COVID-19
Ansun Biopharma, Inc. 280
Large-scale testing (Phase 3)Study completedNCT01257243
What this trial is testing

Comparison Between Oxomemazine, Guaifenesin and Potassium Iodate Versus Guaifenesin Monotherapy in Acute Cough Treatment

Who this might be right for
Cough
EMS 260
Large-scale testing (Phase 3)Study completedNCT01057771
What this trial is testing

Meditation and Exercise for Prevention of Acute Respiratory Infection

Who this might be right for
Acute Respiratory Infection
University of Wisconsin, Madison 154
Testing effectiveness (Phase 2)Study completedNCT04961541
What this trial is testing

Evaluation of the Safety and Immunogenicity of Influenza and COVID-19 Combination Vaccine

Who this might be right for
SARS-CoV InfectionCovid19
Novavax 637
Large-scale testing (Phase 3)Study completedNCT05269290
What this trial is testing

Efficacy and Safety of Ingavirin®, Syrup, 30 mg/5 ml, in Children With Influenza and Other Acute Respiratory Viral Infections

Who this might be right for
Influenza, HumanAcute Respiratory InfectionCommon Cold
Valenta Pharm JSC 240
Large-scale testing (Phase 3)Study completedNCT04682444
What this trial is testing

Efficacy and Safety of Enisamium Iodide for the Treatment of Acute Respiratory Viral Infections, Including Influenza.

Who this might be right for
Acute Respiratory Viral InfectionsHuman Influenza
Joint Stock Company "Farmak" 100
Large-scale testing (Phase 3)Study completedNCT03189537
What this trial is testing

Study of Post-Exposure Ingavirin® Prophylaxis of Influenza and Acute Respiratory Viral Infections

Who this might be right for
Influenza, HumanAcute Respiratory InfectionCommon Cold+2 more
Valenta Pharm JSC 400
Not applicableActive Not RecruitingNCT05019456
What this trial is testing

Exercise and COVID-19 Viral T-cell Immunity

Who this might be right for
COVID-19 Respiratory InfectionInfluenza
University of Arizona 26
Not applicableStudy completedNCT02478905
What this trial is testing

Transmission of Influenza Virus From Asymptomatic Healthcare Workers and Inpatients in the Acute Care Hospital Setting

Who this might be right for
Human Influenza
University of Zurich 700
Not applicableStudy completedNCT06052527
What this trial is testing

Covid-19, Post-Acute Sequelae of SARS-CoV-2 Infection (PASC) and Influenza Treatment System With Machine Learning

Who this might be right for
COVID-19Post-COVID-19 SyndromeInfluenza
Lizora LLC 27
Not applicableActive Not RecruitingNCT07816471
What this trial is testing

RSV, Influenza, and SARS-CoV-2 Outcomes in Severely Immunosuppressed Adults

Who this might be right for
Respiratory Syncytial Virus InfectionsImmunocompromised HostInfluenza+1 more
Hospital Italiano de Buenos Aires 350
Large-scale testing (Phase 3)Looking for participantsNCT07604103
What this trial is testing

Analysis of Growth Differentiation Factor 15 (GDF-15), Mid Regional proAdrenomedullin (MR proADM), and Persepsin Levels in Patient in Acute Coronary Syndrome Patients With Pneumonia, With or Without Influenza Vaccination

Who this might be right for
Acute Coronary Syndromes (ACS)PneumoniaCOPD (Chronic Obstructive Pulmonary Disease)
University of Brawijaya 60
Not applicableStudy completedNCT04239521
What this trial is testing

The Epidemiology, Management, and the Associated Burden of Related Conditions in Alopecia Areata

Who this might be right for
Alopecia AreataDepressive EpisodeRecurrent Depressive Disorder+33 more
Momentum Data 51,955
Large-scale testing (Phase 3)Study completedNCT03191097
What this trial is testing

Efficacy and Safety Study of Ingavirin® to Treat Influenza and Acute Respiratory Viral Infections in Children 7-12 y.o.

Who this might be right for
Influenza, HumanAcute Respiratory InfectionViral Infection+1 more
Valenta Pharm JSC 310
Not applicableStudy completedNCT06278324
What this trial is testing

Effectiveness of a Nasal Spray on Viral Respiratory Infections

Who this might be right for
Acute Respiratory Tract InfectionFlu, HumanCOVID-19+1 more
CEN Biotech 76
Not applicableStudy completedNCT01432340
What this trial is testing

Seasonal Influenza Vaccine Effectiveness Study in Kenya

Who this might be right for
InfluenzaInfluenza Like IllnessSevere Acute Respiratory Illness
Gideon Emukule 10,000
Not applicableEnrolling By InvitationNCT07673250
What this trial is testing

Personalized Ventilator Settings for Patients on ECMO

Who this might be right for
Acute Respiratory Distress Syndrome (ARDS)Extracorporeal Membrane OxygenationRespiratory Failure Patients Treated With ECMO+2 more
University of California, San Diego 62
Large-scale testing (Phase 3)Looking for participantsNCT05624450
What this trial is testing

Efficacy and Safety of Tozorakimab in Patients Hospitalised for Viral Lung Infection Requiring Supplemental Oxygen

Who this might be right for
Viral Lung Infection and Acute Respiratory Failure
AstraZeneca 3,527
Not applicableStudy completedNCT01106196
What this trial is testing

The Role of Influenza as a Trigger for Acute Myocardial Infarction: a CALIBER Study

Who this might be right for
Myocardial InfarctionInfluenza
University College, London 11,208
Testing effectiveness (Phase 2)Looking for participantsNCT06684379
What this trial is testing

Study on Safety and Efficacy of Two Doses of PRS CK STORM in the Modulation of the Cytokine Storm in Patients With Acute Respiratory Infection Caused by SARS-Cov-2, Influenza A, Influenza B and Respiratory Syncytial Virus (RSV)

Who this might be right for
SARS-CoV-2Influenza, HumanRespiratory Syncytial Virus Infections+2 more
PEACHES BIOTECH 50
Next Page